Scientists probe hidden clot risks in autoimmune skin disorders

NCT ID NCT06037187

Recruiting now Knowledge-focused Sponsor: University of Nebraska Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at blood clotting in people with autoimmune skin diseases like bullous pemphigoid and lupus. Researchers will collect blood samples from 39 participants—some with active disease and some with mild or controlled disease—plus 15 healthy controls. They will measure clotting factors and inflammation markers to see how these are linked. No treatment is given; the goal is to gather information for future research.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could point toward new ways to monitor or manage clotting risks in autoimmune skin diseases.
What could go wrong: This is a small, early observational study with only 39 participants. It does not test any treatment, so results may not lead to direct patient benefits.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AUTOIMMUNE BULLOUS DERMATOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

autoimmune bullous skin disease bullous pemphigoid cutaneous lupus erythematosus dermatomyositis mucous membrane pemphigoid pemphigus vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AUTOIMMUNE BULLOUS DERMATOSIS

Contacts and locations

Locations

University of Nebraska Medical Center
RECRUITING

Omaha, Nebraska, 68198, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.